Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Current Taxes: 2011-2025

Historic Current Taxes for Anika Therapeutics (ANIK) over the last 7 years, with Mar 2025 value amounting to $65,000.

  • Anika Therapeutics' Current Taxes fell 95.64% to $65,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $65,000, marking a year-over-year decrease of 95.64%. This contributed to the annual value of $63,000 for FY2024, which is 94.92% down from last year.
  • Latest data reveals that Anika Therapeutics reported Current Taxes of $65,000 as of Q1 2025, which was up 3.17% from $63,000 recorded in Q4 2024.
  • In the past 5 years, Anika Therapeutics' Current Taxes ranged from a high of $1.5 million in Q1 2024 and a low of $63,000 during Q4 2024.
  • Over the past 3 years, Anika Therapeutics' median Current Taxes value was $819,000 (recorded in 2023), while the average stood at $628,444.
  • In the last 5 years, Anika Therapeutics' Current Taxes skyrocketed by 67.60% in 2024 and then tumbled by 95.64% in 2025.
  • Over the past 4 years, Anika Therapeutics' Current Taxes (Quarterly) stood at $810,000 in 2022, then soared by 53.09% to $1.2 million in 2023, then slumped by 94.92% to $63,000 in 2024, then crashed by 95.64% to $65,000 in 2025.
  • Its last three reported values are $65,000 in Q1 2025, $63,000 for Q4 2024, and $82,000 during Q3 2024.